Market Cap ₹8 Cr.
Stock P/E
P/B 1.5
Current Price ₹20.1
Book Value ₹ 13.2
Face Value 10
52W High ₹28.4
Dividend Yield 0%
52W Low ₹ 11.3
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|
| Net Sales | 4 | 6 | 13 | 11 | |
| Other Income | 0 | 0 | 0 | 0 | |
| Total Income | 4 | 6 | 13 | 11 | |
| Total Expenditure | 4 | 6 | 13 | 11 | |
| Operating Profit | 0 | 0 | 0 | 0 | |
| Interest | 0 | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | 0 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
| Profit Before Tax | 0 | 0 | 0 | 0 | |
| Provision for Tax | 0 | 0 | 0 | 0 | |
| Profit After Tax | 0 | 0 | 0 | 0 | |
| Adjustments | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 0 | 0 | 0 | 0 | |
| Adjusted Earnings Per Share | 0 | 0 | 0.3 | 0.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -15% | 40% | 0% | 0% |
| Operating Profit CAGR | 0% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 49% | NA% | NA% | NA% |
| ROE Average | 2% | 2% | 2% | 2% |
| ROCE Average | 3% | 3% | 2% | 2% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Shareholder's Funds | 2 | 2 | 2 | 5 |
| Minority's Interest | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | -0 | -0 | -0 | -0 |
| Total Current Liabilities | 0 | 0 | 0 | 0 |
| Total Liabilities | 2 | 2 | 2 | 5 |
| Fixed Assets | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 |
| Total Current Assets | 2 | 2 | 2 | 5 |
| Total Assets | 2 | 2 | 2 | 5 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 0 | 0 | 1 |
| Cash Flow from Operating Activities | -1 | -0 | 0 | -1 |
| Cash Flow from Investing Activities | 0 | 0 | -0 | -0 |
| Cash Flow from Financing Activities | -0 | -0 | 0 | 3 |
| Net Cash Inflow / Outflow | -0 | -0 | 0 | 2 |
| Closing Cash & Cash Equivalent | 0 | 0 | 1 | 2 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.01 | 0.05 | 0.31 | 0.21 |
| CEPS(Rs) | 0.09 | 0.13 | 0.41 | 0.28 |
| DPS(Rs) | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 8.03 | 8.08 | 8.22 | 13.18 |
| Core EBITDA Margin(%) | -0.15 | 0.35 | 0.94 | 1.11 |
| EBIT Margin(%) | 0.12 | 0.3 | 0.79 | 0.99 |
| Pre Tax Margin(%) | 0.09 | 0.25 | 0.75 | 0.96 |
| PAT Margin (%) | 0.03 | 0.18 | 0.55 | 0.7 |
| Cash Profit Margin (%) | 0.46 | 0.5 | 0.74 | 0.95 |
| ROA(%) | 0.07 | 0.63 | 3.99 | 2.25 |
| ROE(%) | 0.07 | 0.6 | 3.84 | 2.27 |
| ROCE(%) | 0.28 | 0.99 | 5.42 | 3.15 |
| Receivable days | 5.85 | 2.92 | 0.8 | 0.95 |
| Inventory Days | 90.69 | 65.85 | 28.75 | 51.37 |
| Payable days | 0.01 | 0.05 | 0.02 | 0 |
| PER(x) | 0 | 0 | 0 | 62.47 |
| Price/Book(x) | 0 | 0 | 0 | 0.99 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.12 | 0.1 | 0.13 | 0.22 |
| EV/Core EBITDA(x) | 22.95 | 16.43 | 13.24 | 17.72 |
| Net Sales Growth(%) | 0 | 39.69 | 114.16 | -16.27 |
| EBIT Growth(%) | 0 | 248.85 | 473.05 | 4.78 |
| PAT Growth(%) | 0 | 762.78 | 554.98 | 6.55 |
| EPS Growth(%) | 0 | 762.78 | 533.84 | -32.17 |
| Debt/Equity(x) | 0 | 0 | 0.03 | 0.01 |
| Current Ratio(x) | 25.87 | 163.35 | 60.71 | 74.62 |
| Quick Ratio(x) | 9.23 | 53.03 | 28.12 | 41.53 |
| Interest Cover(x) | 3.64 | 6.05 | 18.7 | 31.34 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0.01 |
| # | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Promoter | 41.09 | 41.73 | 42.37 | 43.01 | 43.98 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 |
| Public | 58.91 | 58.27 | 57.63 | 56.99 | 56.02 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Promoter | 0.15 | 0.16 | 0.16 | 0.16 | 0.16 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 |
| Public | 0.22 | 0.22 | 0.22 | 0.21 | 0.21 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Total | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
